《JAMA,3月23日,Ethics Committee Reviews of Applications for Research Studies at 1 Hospital in China During the 2019 Novel Coronavirus Epidemic》

  • 来源专题:COVID-19科研动态监测
  • 编译者: zhangmin
  • 发布时间:2020-03-24
  • Ethics Committee Reviews of Applications for Research Studies at 1 Hospital in China During the 2019 Novel Coronavirus Epidemic

    Hui Zhang, MBBS1; Fengmin Shao, MD, PhD2; Jianqin Gu, MD, PhD3; et al Li Li, MBBS1; Yuming Wang, MD, PhD4

    Author Affiliations Article Information

    JAMA. Published online March 23, 2020. doi:10.1001/jama.2020.4362

    Since December 2019, an epidemic of coronavirus disease 2019 (COVID-19) has spread rapidly from Wuhan, Hubei Province, China.1 As of March 7, there were 1272 confirmed coronavirus cases in Henan Province (the third-highest in China), which adjoins Hubei Province. Due to the high contagiousness of COVID-19 and the current lack of any effective vaccine or drug, scientists and physicians are conducting a series of clinical studies involving affected patients. In 2016, the World Health Organization (WHO) published “Guidance for Managing Ethical Issues in Infectious Disease”2 to ensure the scientific validity of and participants’ rights and safety in studies conducted during outbreaks.

  • 原文来源:https://jamanetwork.com/journals/jama/fullarticle/2763595?resultClick=1
相关报告
  • 《JAMA,6月1日,Mental Health of Young Physicians in China During the Novel Coronavirus Disease 2019 Outbreak》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-06-02
    • Mental Health of Young Physicians in China During the Novel Coronavirus Disease 2019 Outbreak Weidong Li, MD, PhD1; Elena Frank, PhD2; Zhuo Zhao, MS2; et al Lihong Chen, PhD1,2,3; Zhen Wang, MD4; Margit Burmeister, PhD2,5; Srijan Sen, MD, PhD2,5 Author Affiliations Article Information JAMA Netw Open. 2020;3(6):e2010705. doi:10.1001/jamanetworkopen.2020.10705 Introduction With more than 3 million cases worldwide, the novel coronavirus disease 2019 (COVID-19) poses a growing global public health challenge.1 Medical personnel disproportionately bear the additional physical and psychological burdens associated with pandemics, yet the mental health implications of COVID-19 for physicians are unknown.2,3 In this cohort study, we assessed anxiety, depression, mood, and other established factors associated with mental health problems in a cohort of young physicians in China before and during the outbreak. Methods The ethics committees of Shanghai Jiao Tong University and the University of Michigan approved this study. All participants provided written informed consent and were compensated ¥25 (as of May 7, 2020, ¥1 = $0.14 US). This study follows the American Association for Public Opinion Research (AAPOR) reporting guideline.
  • 《JAMA,3月9日,Diagnostic Testing for the Novel Coronavirus》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-03-11
    • Diagnostic Testing for the Novel Coronavirus Joshua M. Sharfstein, MD1; Scott J. Becker, MS2; Michelle M. Mello, JD, PhD3 Author Affiliations Article Information JAMA. Published online March 9, 2020. doi:10.1001/jama.2020.3864 Controversies over diagnostic testing have dominated US headlines about severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the novel coronavirus responsible for coronavirus disease 2019 (COVID-19). Technical challenges with the first test developed by the Centers for Disease Control and Prevention (CDC) left the nation with minimal diagnostic capacity during the first few weeks of the epidemic. The CDC also initially limited access to testing to a narrow group of individuals with known exposure. The delayed discovery of a case of COVID-19 in California, followed quickly by evidence of community transmission in multiple states, revealed the shortcomings of this strategy. In the early stages, COVID-19 has spread beyond the nation’s ability to detect it.